Insider · CIK 0001655597

ABBOT STEWART

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001655597

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-10-16	Turnstone Biologics Corp.Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+45.5K sh	—	—	45,542
2021-06-11	ACETAdicet Bio, Inc. · Non-Qualified Option (right to buy)A Award	See Remarks	AAward	+5,000 sh	—	—	5,000
2021-02-12	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+107K sh	—	—	106,900
2021-01-13	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+80K sh	—	—	80,000
2020-09-17	ACETAdicet Bio, Inc. · Incentive Stock Option (right to buy)A Award	See Remarks	AAward	+63.8K sh	—	—	63,751
2020-09-15	ACETAdicet Bio, Inc. · Employee Stock Option (right to buy)A Award	See Remarks	AAward	+84.8K sh	—	—	84,791
2020-09-15	ACETAdicet Bio, Inc. · Employee Stock Option (right to buy)A Award	See Remarks	AAward	+57.2K sh	—	—	57,151
2018-05-15	FATEFATE THERAPEUTICS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−18.1K sh	—	—	51,862
2018-05-15	FATEFATE THERAPEUTICS INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+2,916 sh	$4.89	+$14.3K	46,779
2018-05-15	FATEFATE THERAPEUTICS INCM Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+18.1K sh	$6.90	+$125K	64,917
2018-05-15	FATEFATE THERAPEUTICS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−2,916 sh	—	—	67,084
2018-01-16	FATEFATE THERAPEUTICS INC · Stock Option (right to buy)A Award	Chief Development Officer	AAward	+186K sh	—	—	186,000
2017-01-04	FATEFATE THERAPEUTICS INC · Stock Option (right to buy)A Award	Chief Development Officer	AAward	+150K sh	—	—	150,000
2016-01-08	FATEFATE THERAPEUTICS INC · Stock Option (right to buy)A Award	Chief Development Officer	AAward	+149K sh	—	—	148,800
2016-01-08	FATEFATE THERAPEUTICS INCA Award	Chief Development Officer	AAward	+3,863 sh	—	—	43,863
2015-10-15	FATEFATE THERAPEUTICS INCA Award	Chief Development Officer	AAward	+40K sh	—	—	40,000
2015-10-15	FATEFATE THERAPEUTICS INC · Stock Option (right to buy)A Award	Chief Development Officer	AAward	+70K sh	—	—	70,000

Recent filings

Accepted (ET)
Oct 174
ABBOT STEWART0001209191-23-052993
SEC(opens sec.gov)
Jun 144
ABBOT STEWART0001209191-21-040232
SEC(opens sec.gov)
Feb 174
ABBOT STEWART0000899243-21-007032
SEC(opens sec.gov)
Jan 154
ABBOT STEWART0000899243-21-002188
SEC(opens sec.gov)
Sep 174
ABBOT STEWART0000899243-20-025646
SEC(opens sec.gov)
May 164
ABBOT STEWART0001209191-18-030617
SEC(opens sec.gov)
Jan 174
ABBOT STEWART0001209191-18-003918
SEC(opens sec.gov)
Jan 64
FATE THERAPEUTICS INC0001209191-17-002628
SEC(opens sec.gov)
Jan 124
FATE THERAPEUTICS INC0001209191-16-091055
SEC(opens sec.gov)
Oct 164
FATE THERAPEUTICS INC0001104659-15-071110
SEC(opens sec.gov)

Companies

Address

C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200

SAN DIEGO, CA, 92121